Anti-tumoral capabilities of effector cells after IFN-α or CpG-motif treatment of cocultured dendritic cells
Michael Erhardt(University of Bonn), Marcus Gorschlüter(University of Bonn), Marie von Lilienfeld‐Toal(St James's University Hospital), Susanne Frank(University Hospital Bonn), Ingo G.H. Schmidt‐Wolf(University Hospital Bonn), Elisabeth Sievers(Karolinska University Hospital), John Strehl(University of Bonn)
Cited by 8
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
|Blood|2010|485
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450